Astrazeneca AZN
NYSE AZN
$188.59 +2.16 (+1.16%)
As of: Nov 9, 2026 · 12:08 PM EST

Astrazeneca (AZN) Gains (Losses) on Sale of Assets & Investments (2016 - 2023)

Updated

Analysis

Astrazeneca (AZN) Gains (Losses) on Sale of Assets & Investments (2016 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gains on Sales (Qtr)
1 Eli Lilly 1,246.80 Bn 1,220.42 Bn 20.46 Bn -
2 Johnson & Johnson 674.35 Bn 594.21 Bn 17.30 Bn -
3 AbbVie 517.12 Bn 485.13 Bn 13.12 Bn -
4 Merck 364.12 Bn 327.06 Bn 13.19 Bn -
5 Novartis Ag 315.40 Bn 288.64 Bn - -
6 Astrazeneca 292.28 Bn 266.18 Bn 13.26 Bn -
7 Amgen 250.93 Bn 202.58 Bn 7.58 Bn -
8 Gilead Sciences 209.69 Bn 184.80 Bn 6.73 Bn -
9 Pfizer 167.04 Bn 114.40 Bn 12.56 Bn -
10 Vertex Pharmaceuticals 138.41 Bn 110.40 Bn 2.91 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 1.47 Bn
Dec 31, 2022 1.71 Bn
Sep 30, 2022 668.00 Mn
Jun 30, 2022 -372.00 Mn
Dec 31, 2021 -746.00 Mn
Sep 30, 2021 -1.98 Bn
Dec 31, 2020 1.93 Bn
Sep 30, 2020 1.09 Bn
Jun 30, 2020 1.42 Bn
Dec 31, 2019 1.42 Bn
Sep 30, 2019 -275.00 Mn
Dec 31, 2017 -865.00 Mn
Sep 30, 2017 1.14 Bn
Jun 30, 2017 669.00 Mn
Sep 30, 2016 628.00 Mn
Jun 30, 2016 -1.15 Bn
API Access

Astrazeneca Gains (Losses) on Sale of Assets & Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=AZN&period=max&api_key=YOUR_API_KEY